| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6848017 | Research in Autism Spectrum Disorders | 2016 | 18 Pages |
Abstract
A total of 43 studies were included in the analysis. The results indicate that only two medications, fluoxetine and risperidone, can be considered as promising evidence-based practices for adults with ASD. Given the rising prevalence of ASD, along with increased use of psychopharmacologic intervention in this population, there is a clear need for methodologically rigorous research to establish the effectiveness of these interventions. The subsequent establishment of clinical guidelines for medication use in this population is essential.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Lauren J. Taylor,